Octave Bioscience’s Comprehensive Care Platform provides a quantitative, objective measurement system designed to expand clinical insights in neurodegenerative disease, beginning with MS. It provides multiple layers of insight to provide a 360 degree view with a longitudinal perspective of disease progression. The first layer measures the patient’s underlying biology with blood based biomarkers that quantitatively and objectively assess inflammation and immune modulation. The second layer includes advanced measurement using improved MRI readings and interpretation to reveal more insights at the CNS layer, including the brain and spine. The final layer features real time tracking of symptoms via monitoring with mobile tools, sensors and wearables to identify changes in disease and alert care teams. All of this data is integrated into protocols, supported by decision support tools and feeds into a dashboard for ease of use. The Octave Platform allows individual and population views to facilitate better stratification and contextual interventions.

Biotechnology

Octave Bioscience

Octave Bioscience's headquarters in West Menlo Park, CA, United States

William Hagstrom

Nickolas Mark

Brian Burke

Marcel Konrad

Jeron Evans

Reto Matter

Ferhan Qureshi

Amanda Champion

Mike Edgeworth

Grant Heidrich III

Tom Hawes

George Scangos

Brook Byers

Michael Pellini

Andrea Jackson

Description

People (4)

Alexander Hari

Marcel Konrad

Azade Sanjari

Sarah Eagleman

Jobs